Ardelyx | ARDX - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.54B 625M 2025-12
Amgen USD 6.48B 307M 2025-09
Ardelyx USD 114.37M 8.02M 2025-12
aTyr Pharma USD 190K 15.57M 2025-09
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Curis USD -7.72M 140K 2024-06
Sanofi EUR 8.45B 3.02B 2025-12
TG Therapeutics USD 154.43M 20.81M 2025-12
United Therapeutics USD 315.5M 286.6M 2025-12
Xoma 992K 846K 2024-06